$0.980
+0.037 (+3.77%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AKBA por análisis de gráficos similares
Alphio's AKBA stock price prediction model matches the current Akebia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.95 (-2.68%). The 1-week path is $0.99 (+0.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Akebia Therapeutics Inc?
Akebia Therapeutics Inc is not a good buy right now due to declining revenues and negative earnings reports. The current price is $0.8786, with a 21.6% year-over-year revenue decline reported in Q2 2026, despite a slight earnings surprise. Additionally, the RSI is at 38.919, indicating oversold conditions, but the overall trend remains negative with a 71.75% decline over the past year, suggesting further downside risk.
AKBA cerró en $0.98 el Wednesday, tras subir +3.77%
Akebia Therapeutics Inc (AKBA) last closed at $0.9803, gaining +3.77%. These facts feed the 1-day and 1-week AKBA price prediction above.
Consenso de analistas
Akebia Therapeutics Inc (AKBA): 6 comprar, 1 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Akebia Therapeutics Inc (AKBA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AKBA, ordenadas por similitud.
Análisis de estacionalidad de AKBA
Historically the probability of a positive September return for AKBA is 95.35%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de AKBA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $2.69 | $3.24 | $3.82 | +230.66% |
| Oct 2026 | $4.05 | $4.09 | $4.46 | +317.68% |
| Nov 2026 | $3.15 | $3.98 | $4.61 | +306.06% |
| Dec 2026 | $2.84 | $3.65 | $4.36 | +272.39% |
En 2026, se proyecta que Akebia Therapeutics Inc (AKBA) oscile entre $2.69 y $4.61.
Previsión mensual de Akebia Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Akebia Therapeutics Inc promedie $3.24, con un mínimo de $2.69 y un máximo de $3.82.
En Oct de 2026, se proyecta que Akebia Therapeutics Inc promedie $4.09, con un mínimo de $4.05 y un máximo de $4.46.
En Nov de 2026, se proyecta que Akebia Therapeutics Inc promedie $3.98, con un mínimo de $3.15 y un máximo de $4.61.
En Dec de 2026, se proyecta que Akebia Therapeutics Inc promedie $3.65, con un mínimo de $2.84 y un máximo de $4.36.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.